Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Cystic Fibrosis · Multiple Sclerosis · RARE

Ultragenyx UK

Ultragenyx UK Limited

Ultragenyx UK patent portfolio — 23 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Newcastle upon tyne, NE128RL, GB, NOVATO, CA HQ
2024 Founded
2 Employees
Public company Type
RARE · NYSE Ticker
Company details
Status
Public
HQ
Newcastle upon tyne, NE128RL, GB, NOVATO, CA
Founded
2024
Employees
2
Programs
201
Drugs
168
Patents
23
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Ultragenyx UK patents

23 pharmaceutical patents indexed for Ultragenyx UK. 0 expire within 24 months.

Ultragenyx UK has 23 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

23 patents

Patent portfolio

  1. US 12358976

    Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12338450

    Gene therapy constructs for treating Wilson disease

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11944658

    Methods of heat inactivation of adenovirus

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11771748

    Methods for treating tumor-induced osteomalacia

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11753369

    Creatine prodrugs, compositions and methods of use thereof

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11377643

    Therapeutics for glycogen storage disease type III

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11332438

    Creatine prodrugs, compositions and methods of use thereof

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11202822

    Methods for treating hypophosphatemic disorders

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11013774

    Methods of heat inactivation of adenovirus

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10889607

    Sialic acid analogs

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10639360

    Methods for treating hypophosphatemic disorders

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10457701

    Sialic acid analogs

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10385085

    Crystal forms of sialic acid or salt or solvate thereof

    Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10065981

    Sialic acid analogs

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9937243

    Sialylated glycoprotein compositions and uses thereof

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9687532

    Sialylated glycoprotein compositons and uses thereof

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9554987

    Methods and formulations for treating sialic acid deficiencies

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9511015

    Methods and formulations for treating sialic acid deficiencies

    Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9457067

    Sialylated glycoprotein compositions and uses thereof

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9457068

    Sialylated glycoprotein compositions and uses thereof

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9241896

    Methods and formulations for treating sialic acid deficiencies

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9221858

    Sialic acid analogs

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8840926

    Sialic acid analogs

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Ultragenyx UK have?

23 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Ultragenyx UK patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.